A detailed history of High Note Wealth, LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, High Note Wealth, LLC holds 357 shares of DVAX stock, worth $4,019. This represents 0.0% of its overall portfolio holdings.

Number of Shares
357
Holding current value
$4,019
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 01, 2025

BUY
$12.39 - $14.4 $4,423 - $5,140
357 New
357 $4,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.42B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track High Note Wealth, LLC Portfolio

Follow High Note Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Note Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Note Wealth, LLC with notifications on news.